Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang Fu

Showing results (861-870 of 864) with videos related to

Pageof 87
Sort By:
You have reached the last page of results.This site can display upto 864 results.
NPJ Biofilms and Microbiomes|March 21, 2024
Lactobacillus rhamnosus GG ameliorates hyperuricemia in a novel modelYang Fu, Yong-Song Chen, Dai-Yang Xia, et al.
Nature Medicine|March 27, 2025
Author Correction: First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trialLin Shen, Yanqiao Zhang, Ziyu Li, et al.
Nature Medicine|January 22, 2025
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trialLin Shen, Yanqiao Zhang, Ziyu Li, et al.
Allergy|September 13, 2025
International Evidence-Based Guidelines for Traditional Chinese Medicine Management of Allergic RhinitisQin-Wei Fu, Peng Liu, Yan Ruan, et al.
Pageof 87

Showing results (861-870 of 864) with videos related to

Sort By:
Pageof 87
You have reached the last page of results.This site can display upto 864 results.
NPJ Biofilms and Microbiomes|March 21, 2024
Lactobacillus rhamnosus GG ameliorates hyperuricemia in a novel modelYang Fu, Yong-Song Chen, Dai-Yang Xia, et al.
Nature Medicine|March 27, 2025
Author Correction: First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trialLin Shen, Yanqiao Zhang, Ziyu Li, et al.
Nature Medicine|January 22, 2025
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trialLin Shen, Yanqiao Zhang, Ziyu Li, et al.
Allergy|September 13, 2025
International Evidence-Based Guidelines for Traditional Chinese Medicine Management of Allergic RhinitisQin-Wei Fu, Peng Liu, Yan Ruan, et al.
Pageof 87